GO FUND IT NOW

Defense Health Agency Contracting Activity - DHACA

DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development Award

DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development Award is a funding opportunity from Defense Health Agency Contracting Activity - DHACA, closing September 30, 2026.

Funder
Defense Health Agency Contracting Activity - DHACA
Funding
Grant / contract
Deadline
Sep 30, 2026
(61d left)

Overview

Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Development Award (TDA) supports research ranging from preclinical validation of therapeutic leads through U.S. Food and Drug Administration (FDA) Investigational New Drug (IND)-enabling studies. The proposed…

DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development Award | Go Fund It Now